معرفی
Conroy Chow, MD, is an Associate Professor in the Department of Dermatology at Loma Linda University School of Medicine. He is actively involved in clinical and academic dermatology, with a strong focus on dermatologic surgery and patient outcomes.
Research Interests: Dr. Chow's research spans dermatologic surgery, Mohs micrographic surgery, histopathological accuracy, patient satisfaction, and treatment efficacy in skin diseases. His work investigates clinical outcomes, diagnostic concordance, and the impact of patient reviews on dermatologic practice. He has contributed significantly to understanding postoperative care, antibiotic use, and rare skin tumors.
Publication Trends: His recent publications (2019–2025) reflect a consistent focus on quality improvement in dermatologic surgery, patient-centered care, and evidence-based dermatology. Articles analyze population-level data, survey academic dermatologists, and review diagnostic practices, demonstrating a multidisciplinary approach integrating surgery, pathology, and patient experience.
Scientific Contributions:
- Principal Investigator on studies involving wound healing and rare cutaneous tumors
- Investigator in industry-sponsored trials
- Active contributor to peer-reviewed journals including Journal of the American Academy of Dermatology and International Journal of Dermatology
Grants and Research Projects:
- PI, Internal Use of Topical Silver Sulfadiazine for Granulating Wounds after Mohs Surgery (LLU Dept. of Dermatology, 2023)
- PI, Retrospective Review of Granulating Wounds and Use of Topical Silver Sulfadiazine (LLU Dept. of Dermatology, 2023)
- Investigator, Rare Cutaneous Tumors Multisite Study (LLU Dept. of Dermatology, 2023)
- Investigator, Phase 3 Study of Apomorphine in Parkinson’s Disease (U.S. World Meds, 2021–2022)
Labs and Teams: Dr. Chow collaborates closely with a multidisciplinary team including dermatopathologists, Mohs surgeons, and researchers, notably Dr. Ashley Elsensohn. His work is centered within the academic dermatology division at Loma Linda University, contributing to both clinical innovation and scholarly output.
